nodes	percent_of_prediction	percent_of_DWPC	metapath
Milrinone—PDE3A—penis—prostate cancer	0.212	0.704	CbGeAlD
Milrinone—PDE3A—prostate gland—prostate cancer	0.0508	0.168	CbGeAlD
Milrinone—Infusion site reaction—Docetaxel—prostate cancer	0.033	0.0512	CcSEcCtD
Milrinone—PDE3A—testis—prostate cancer	0.0224	0.0741	CbGeAlD
Milrinone—Ventricular fibrillation—Cabazitaxel—prostate cancer	0.0218	0.034	CcSEcCtD
Milrinone—PDE3A—lymph node—prostate cancer	0.0162	0.0537	CbGeAlD
Milrinone—Liver function test abnormal—Estramustine—prostate cancer	0.015	0.0233	CcSEcCtD
Milrinone—Hypokalaemia—Abiraterone—prostate cancer	0.0144	0.0223	CcSEcCtD
Milrinone—Arrhythmia supraventricular—Capecitabine—prostate cancer	0.0127	0.0198	CcSEcCtD
Milrinone—Angina pectoris—Nilutamide—prostate cancer	0.0122	0.0189	CcSEcCtD
Milrinone—Hypokalaemia—Cabazitaxel—prostate cancer	0.0111	0.0172	CcSEcCtD
Milrinone—Arrhythmia—Abiraterone—prostate cancer	0.00976	0.0152	CcSEcCtD
Milrinone—Liver function test abnormal—Bicalutamide—prostate cancer	0.00962	0.015	CcSEcCtD
Milrinone—Angina pectoris—Bicalutamide—prostate cancer	0.00877	0.0136	CcSEcCtD
Milrinone—Ventricular extrasystoles—Estradiol—prostate cancer	0.00876	0.0136	CcSEcCtD
Milrinone—Chest pain—Estramustine—prostate cancer	0.00834	0.013	CcSEcCtD
Milrinone—Chest pain—Abiraterone—prostate cancer	0.0081	0.0126	CcSEcCtD
Milrinone—Arrhythmia—Degarelix—prostate cancer	0.00797	0.0124	CcSEcCtD
Milrinone—Thrombocytopenia—Estramustine—prostate cancer	0.00783	0.0122	CcSEcCtD
Milrinone—Anaphylactic shock—Estrone—prostate cancer	0.00764	0.0119	CcSEcCtD
Milrinone—Arrhythmia—Cabazitaxel—prostate cancer	0.00751	0.0117	CcSEcCtD
Milrinone—Chest pain—Nilutamide—prostate cancer	0.0074	0.0115	CcSEcCtD
Milrinone—Torsade de pointes—Capecitabine—prostate cancer	0.00704	0.0109	CcSEcCtD
Milrinone—Thrombocytopenia—Flutamide—prostate cancer	0.00691	0.0107	CcSEcCtD
Milrinone—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.00667	0.0104	CcSEcCtD
Milrinone—Hypokalaemia—Conjugated Estrogens—prostate cancer	0.00653	0.0102	CcSEcCtD
Milrinone—Ventricular fibrillation—Capecitabine—prostate cancer	0.00645	0.01	CcSEcCtD
Milrinone—Arrhythmia—Bicalutamide—prostate cancer	0.00644	0.01	CcSEcCtD
Milrinone—Anaphylactic shock—Degarelix—prostate cancer	0.00634	0.00985	CcSEcCtD
Milrinone—Chest pain—Cabazitaxel—prostate cancer	0.00623	0.00968	CcSEcCtD
Milrinone—Bronchospasm—Conjugated Estrogens—prostate cancer	0.0061	0.00949	CcSEcCtD
Milrinone—Angina pectoris—Goserelin—prostate cancer	0.0061	0.00948	CcSEcCtD
Milrinone—Hypotension—Degarelix—prostate cancer	0.00592	0.0092	CcSEcCtD
Milrinone—Thrombocytopenia—Cabazitaxel—prostate cancer	0.00584	0.00908	CcSEcCtD
Milrinone—Hypotension—Cabazitaxel—prostate cancer	0.00558	0.00867	CcSEcCtD
Milrinone—Ventricular extrasystoles—Capecitabine—prostate cancer	0.00546	0.00849	CcSEcCtD
Milrinone—Chest pain—Bicalutamide—prostate cancer	0.00534	0.0083	CcSEcCtD
Milrinone—Liver function test abnormal—Estradiol—prostate cancer	0.0053	0.00824	CcSEcCtD
Milrinone—Rash—Estramustine—prostate cancer	0.00504	0.00783	CcSEcCtD
Milrinone—Dermatitis—Estramustine—prostate cancer	0.00504	0.00783	CcSEcCtD
Milrinone—Thrombocytopenia—Bicalutamide—prostate cancer	0.00501	0.00779	CcSEcCtD
Milrinone—Headache—Estramustine—prostate cancer	0.00501	0.00778	CcSEcCtD
Milrinone—Rash—Abiraterone—prostate cancer	0.0049	0.00761	CcSEcCtD
Milrinone—Dermatitis—Abiraterone—prostate cancer	0.00489	0.0076	CcSEcCtD
Milrinone—Bronchospasm—Estradiol—prostate cancer	0.00488	0.00759	CcSEcCtD
Milrinone—Hypokalaemia—Mitoxantrone—prostate cancer	0.00487	0.00757	CcSEcCtD
Milrinone—Rash—Estrone—prostate cancer	0.00482	0.00748	CcSEcCtD
Milrinone—Dermatitis—Estrone—prostate cancer	0.00481	0.00748	CcSEcCtD
Milrinone—Headache—Estrone—prostate cancer	0.00478	0.00744	CcSEcCtD
Milrinone—Ventricular arrhythmia—Epirubicin—prostate cancer	0.00465	0.00722	CcSEcCtD
Milrinone—Arrhythmia—Goserelin—prostate cancer	0.00448	0.00696	CcSEcCtD
Milrinone—Rash—Nilutamide—prostate cancer	0.00447	0.00695	CcSEcCtD
Milrinone—Dermatitis—Nilutamide—prostate cancer	0.00447	0.00695	CcSEcCtD
Milrinone—Rash—Flutamide—prostate cancer	0.00445	0.00692	CcSEcCtD
Milrinone—Dermatitis—Flutamide—prostate cancer	0.00445	0.00691	CcSEcCtD
Milrinone—Headache—Nilutamide—prostate cancer	0.00444	0.00691	CcSEcCtD
Milrinone—Arrhythmia—Conjugated Estrogens—prostate cancer	0.00444	0.0069	CcSEcCtD
Milrinone—Headache—Flutamide—prostate cancer	0.00442	0.00688	CcSEcCtD
Milrinone—Ventricular arrhythmia—Doxorubicin—prostate cancer	0.0043	0.00668	CcSEcCtD
Milrinone—Rash—Estradiol valerate/Dienogest—prostate cancer	0.0042	0.00653	CcSEcCtD
Milrinone—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.0042	0.00653	CcSEcCtD
Milrinone—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00418	0.00649	CcSEcCtD
Milrinone—Rash—Degarelix—prostate cancer	0.004	0.00621	CcSEcCtD
Milrinone—Dermatitis—Degarelix—prostate cancer	0.00399	0.0062	CcSEcCtD
Milrinone—Headache—Degarelix—prostate cancer	0.00397	0.00617	CcSEcCtD
Milrinone—Ventricular extrasystoles—Epirubicin—prostate cancer	0.00381	0.00592	CcSEcCtD
Milrinone—Bronchospasm—Etoposide—prostate cancer	0.00379	0.00588	CcSEcCtD
Milrinone—Headache—Cabazitaxel—prostate cancer	0.00374	0.00581	CcSEcCtD
Milrinone—Chest pain—Goserelin—prostate cancer	0.00372	0.00578	CcSEcCtD
Milrinone—Chest pain—Conjugated Estrogens—prostate cancer	0.00368	0.00572	CcSEcCtD
Milrinone—Anaphylactic shock—Goserelin—prostate cancer	0.00356	0.00554	CcSEcCtD
Milrinone—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.00353	0.00548	CcSEcCtD
Milrinone—Ventricular extrasystoles—Doxorubicin—prostate cancer	0.00352	0.00548	CcSEcCtD
Milrinone—Thrombocytopenia—Goserelin—prostate cancer	0.00349	0.00542	CcSEcCtD
Milrinone—Ventricular tachycardia—Epirubicin—prostate cancer	0.00344	0.00535	CcSEcCtD
Milrinone—Liver function test abnormal—Docetaxel—prostate cancer	0.00342	0.00531	CcSEcCtD
Milrinone—Hypotension—Goserelin—prostate cancer	0.00333	0.00517	CcSEcCtD
Milrinone—Arrhythmia—Mitoxantrone—prostate cancer	0.00331	0.00514	CcSEcCtD
Milrinone—Liver function test abnormal—Capecitabine—prostate cancer	0.00331	0.00514	CcSEcCtD
Milrinone—Hypotension—Conjugated Estrogens—prostate cancer	0.0033	0.00512	CcSEcCtD
Milrinone—Hypokalaemia—Capecitabine—prostate cancer	0.00326	0.00507	CcSEcCtD
Milrinone—Tremor—Estradiol—prostate cancer	0.00324	0.00504	CcSEcCtD
Milrinone—Rash—Bicalutamide—prostate cancer	0.00323	0.00502	CcSEcCtD
Milrinone—Dermatitis—Bicalutamide—prostate cancer	0.00323	0.00501	CcSEcCtD
Milrinone—Headache—Bicalutamide—prostate cancer	0.00321	0.00499	CcSEcCtD
Milrinone—Ventricular tachycardia—Doxorubicin—prostate cancer	0.00318	0.00495	CcSEcCtD
Milrinone—PDE3A—cGMP effects—ITPR1—prostate cancer	0.00315	0.0575	CbGpPWpGaD
Milrinone—Bronchospasm—Docetaxel—prostate cancer	0.00315	0.00489	CcSEcCtD
Milrinone—Angina pectoris—Docetaxel—prostate cancer	0.00312	0.00484	CcSEcCtD
Milrinone—Bronchospasm—Capecitabine—prostate cancer	0.00305	0.00473	CcSEcCtD
Milrinone—Angina pectoris—Capecitabine—prostate cancer	0.00302	0.00469	CcSEcCtD
Milrinone—Chest pain—Estradiol—prostate cancer	0.00295	0.00458	CcSEcCtD
Milrinone—Hypokalaemia—Prednisone—prostate cancer	0.0029	0.00451	CcSEcCtD
Milrinone—Anaphylactic shock—Estradiol—prostate cancer	0.00282	0.00439	CcSEcCtD
Milrinone—Chest pain—Mitoxantrone—prostate cancer	0.00274	0.00427	CcSEcCtD
Milrinone—Rash—Ethinyl Estradiol—prostate cancer	0.00273	0.00424	CcSEcCtD
Milrinone—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00273	0.00424	CcSEcCtD
Milrinone—Headache—Ethinyl Estradiol—prostate cancer	0.00271	0.00421	CcSEcCtD
Milrinone—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00263	0.00409	CcSEcCtD
Milrinone—Thrombocytopenia—Mitoxantrone—prostate cancer	0.00258	0.004	CcSEcCtD
Milrinone—PDE3A—Nitric oxide stimulates guanylate cyclase—ITPR1—prostate cancer	0.00251	0.0457	CbGpPWpGaD
Milrinone—Hypotension—Mitoxantrone—prostate cancer	0.00246	0.00382	CcSEcCtD
Milrinone—PDE3A—G alpha (s) signalling events—RLN2—prostate cancer	0.00232	0.0424	CbGpPWpGaD
Milrinone—Liver function test abnormal—Epirubicin—prostate cancer	0.0023	0.00358	CcSEcCtD
Milrinone—Arrhythmia—Docetaxel—prostate cancer	0.00229	0.00355	CcSEcCtD
Milrinone—Chest pain—Etoposide—prostate cancer	0.00228	0.00355	CcSEcCtD
Milrinone—Hypokalaemia—Epirubicin—prostate cancer	0.00227	0.00353	CcSEcCtD
Milrinone—Rash—Goserelin—prostate cancer	0.00225	0.00349	CcSEcCtD
Milrinone—Dermatitis—Goserelin—prostate cancer	0.00224	0.00349	CcSEcCtD
Milrinone—Headache—Goserelin—prostate cancer	0.00223	0.00347	CcSEcCtD
Milrinone—Rash—Conjugated Estrogens—prostate cancer	0.00222	0.00346	CcSEcCtD
Milrinone—Dermatitis—Conjugated Estrogens—prostate cancer	0.00222	0.00345	CcSEcCtD
Milrinone—Arrhythmia—Capecitabine—prostate cancer	0.00221	0.00344	CcSEcCtD
Milrinone—Headache—Conjugated Estrogens—prostate cancer	0.00221	0.00344	CcSEcCtD
Milrinone—Anaphylactic shock—Etoposide—prostate cancer	0.00219	0.0034	CcSEcCtD
Milrinone—Thrombocytopenia—Etoposide—prostate cancer	0.00214	0.00333	CcSEcCtD
Milrinone—Liver function test abnormal—Doxorubicin—prostate cancer	0.00213	0.00331	CcSEcCtD
Milrinone—Hypokalaemia—Doxorubicin—prostate cancer	0.0021	0.00327	CcSEcCtD
Milrinone—Angina pectoris—Epirubicin—prostate cancer	0.0021	0.00327	CcSEcCtD
Milrinone—Hypotension—Etoposide—prostate cancer	0.00205	0.00318	CcSEcCtD
Milrinone—Tremor—Capecitabine—prostate cancer	0.00202	0.00314	CcSEcCtD
Milrinone—Arrhythmia—Prednisone—prostate cancer	0.00197	0.00307	CcSEcCtD
Milrinone—Angina pectoris—Doxorubicin—prostate cancer	0.00194	0.00302	CcSEcCtD
Milrinone—Chest pain—Docetaxel—prostate cancer	0.0019	0.00295	CcSEcCtD
Milrinone—Chest pain—Capecitabine—prostate cancer	0.00184	0.00286	CcSEcCtD
Milrinone—Anaphylactic shock—Docetaxel—prostate cancer	0.00182	0.00283	CcSEcCtD
Milrinone—Thrombocytopenia—Docetaxel—prostate cancer	0.00178	0.00277	CcSEcCtD
Milrinone—Rash—Estradiol—prostate cancer	0.00178	0.00277	CcSEcCtD
Milrinone—Dermatitis—Estradiol—prostate cancer	0.00178	0.00276	CcSEcCtD
Milrinone—Headache—Estradiol—prostate cancer	0.00177	0.00275	CcSEcCtD
Milrinone—Thrombocytopenia—Capecitabine—prostate cancer	0.00172	0.00268	CcSEcCtD
Milrinone—Hypotension—Docetaxel—prostate cancer	0.0017	0.00264	CcSEcCtD
Milrinone—PDE3A—G alpha (s) signalling events—MC2R—prostate cancer	0.00168	0.0306	CbGpPWpGaD
Milrinone—Rash—Mitoxantrone—prostate cancer	0.00166	0.00258	CcSEcCtD
Milrinone—Dermatitis—Mitoxantrone—prostate cancer	0.00166	0.00258	CcSEcCtD
Milrinone—Headache—Mitoxantrone—prostate cancer	0.00165	0.00256	CcSEcCtD
Milrinone—Hypotension—Capecitabine—prostate cancer	0.00165	0.00256	CcSEcCtD
Milrinone—PDE3A—Platelet homeostasis—GNG5—prostate cancer	0.00161	0.0293	CbGpPWpGaD
Milrinone—Anaphylactic shock—Prednisone—prostate cancer	0.00157	0.00244	CcSEcCtD
Milrinone—Arrhythmia—Epirubicin—prostate cancer	0.00154	0.0024	CcSEcCtD
Milrinone—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS3—prostate cancer	0.00144	0.0263	CbGpPWpGaD
Milrinone—Arrhythmia—Doxorubicin—prostate cancer	0.00143	0.00222	CcSEcCtD
Milrinone—Rash—Etoposide—prostate cancer	0.00138	0.00214	CcSEcCtD
Milrinone—Dermatitis—Etoposide—prostate cancer	0.00138	0.00214	CcSEcCtD
Milrinone—Headache—Etoposide—prostate cancer	0.00137	0.00213	CcSEcCtD
Milrinone—Chest pain—Epirubicin—prostate cancer	0.00128	0.00199	CcSEcCtD
Milrinone—PDE3A—G alpha (s) signalling events—VIP—prostate cancer	0.00127	0.0232	CbGpPWpGaD
Milrinone—Anaphylactic shock—Epirubicin—prostate cancer	0.00123	0.00191	CcSEcCtD
Milrinone—Thrombocytopenia—Epirubicin—prostate cancer	0.0012	0.00187	CcSEcCtD
Milrinone—Chest pain—Doxorubicin—prostate cancer	0.00118	0.00184	CcSEcCtD
Milrinone—PDE3A—G alpha (s) signalling events—PDE4D—prostate cancer	0.00116	0.0212	CbGpPWpGaD
Milrinone—Rash—Docetaxel—prostate cancer	0.00115	0.00178	CcSEcCtD
Milrinone—Hypotension—Epirubicin—prostate cancer	0.00115	0.00178	CcSEcCtD
Milrinone—Dermatitis—Docetaxel—prostate cancer	0.00115	0.00178	CcSEcCtD
Milrinone—Headache—Docetaxel—prostate cancer	0.00114	0.00177	CcSEcCtD
Milrinone—Anaphylactic shock—Doxorubicin—prostate cancer	0.00114	0.00176	CcSEcCtD
Milrinone—Thrombocytopenia—Doxorubicin—prostate cancer	0.00111	0.00173	CcSEcCtD
Milrinone—Rash—Capecitabine—prostate cancer	0.00111	0.00173	CcSEcCtD
Milrinone—Dermatitis—Capecitabine—prostate cancer	0.00111	0.00172	CcSEcCtD
Milrinone—PDE3A—G alpha (s) signalling events—GNG5—prostate cancer	0.00111	0.0202	CbGpPWpGaD
Milrinone—Headache—Capecitabine—prostate cancer	0.0011	0.00171	CcSEcCtD
Milrinone—Hypotension—Doxorubicin—prostate cancer	0.00106	0.00165	CcSEcCtD
Milrinone—PDE3A—Hemostasis—HBG1—prostate cancer	0.000996	0.0182	CbGpPWpGaD
Milrinone—Rash—Prednisone—prostate cancer	0.000989	0.00154	CcSEcCtD
Milrinone—Dermatitis—Prednisone—prostate cancer	0.000988	0.00154	CcSEcCtD
Milrinone—Headache—Prednisone—prostate cancer	0.000983	0.00153	CcSEcCtD
Milrinone—PDE3A—Platelet homeostasis—ITPR1—prostate cancer	0.000976	0.0178	CbGpPWpGaD
Milrinone—PDE3A—G alpha (s) signalling events—PTHLH—prostate cancer	0.000965	0.0176	CbGpPWpGaD
Milrinone—PDE3A—G alpha (s) signalling events—CALCA—prostate cancer	0.00085	0.0155	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—TMSB4X—prostate cancer	0.000847	0.0154	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—HBG2—prostate cancer	0.000847	0.0154	CbGpPWpGaD
Milrinone—Rash—Epirubicin—prostate cancer	0.000774	0.0012	CcSEcCtD
Milrinone—Dermatitis—Epirubicin—prostate cancer	0.000773	0.0012	CcSEcCtD
Milrinone—Headache—Epirubicin—prostate cancer	0.000769	0.00119	CcSEcCtD
Milrinone—Rash—Doxorubicin—prostate cancer	0.000716	0.00111	CcSEcCtD
Milrinone—Dermatitis—Doxorubicin—prostate cancer	0.000715	0.00111	CcSEcCtD
Milrinone—PDE3A—G alpha (s) signalling events—ADRB2—prostate cancer	0.000712	0.013	CbGpPWpGaD
Milrinone—Headache—Doxorubicin—prostate cancer	0.000711	0.00111	CcSEcCtD
Milrinone—PDE3A—Hemostasis—STX4—prostate cancer	0.00069	0.0126	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—RAD51B—prostate cancer	0.00069	0.0126	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—OR51E2—prostate cancer	0.000629	0.0115	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—F9—prostate cancer	0.000621	0.0113	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—OR51E2—prostate cancer	0.000571	0.0104	CbGpPWpGaD
Milrinone—PDE3A—Platelet homeostasis—NOS3—prostate cancer	0.000562	0.0102	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—RGS17—prostate cancer	0.000535	0.00976	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—ITGA6—prostate cancer	0.000486	0.00887	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—RGS17—prostate cancer	0.000486	0.00886	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—RLN2—prostate cancer	0.000477	0.0087	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—CD9—prostate cancer	0.000457	0.00834	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PLXNB1—prostate cancer	0.000436	0.00795	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—RLN2—prostate cancer	0.000433	0.0079	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—GRPR—prostate cancer	0.00042	0.00766	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—CLU—prostate cancer	0.000413	0.00754	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PLXNB1—prostate cancer	0.000396	0.00722	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—GRPR—prostate cancer	0.000381	0.00695	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—GRB7—prostate cancer	0.000378	0.0069	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—GNG5—prostate cancer	0.00036	0.00656	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—MC2R—prostate cancer	0.000345	0.00629	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—OR51E2—prostate cancer	0.000338	0.00616	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—WNT4—prostate cancer	0.000328	0.00598	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—MC2R—prostate cancer	0.000313	0.00571	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—BMPR1B—prostate cancer	0.000309	0.00563	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PENK—prostate cancer	0.000307	0.0056	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PRKACB—prostate cancer	0.000307	0.00559	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—THBS1—prostate cancer	0.000299	0.00545	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PRKCZ—prostate cancer	0.000289	0.00527	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RGS17—prostate cancer	0.000287	0.00523	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PENK—prostate cancer	0.000279	0.00509	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—GNRH1—prostate cancer	0.000261	0.00476	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—VIP—prostate cancer	0.000261	0.00476	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RLN2—prostate cancer	0.000256	0.00467	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—LPAR1—prostate cancer	0.000253	0.00461	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—GRP—prostate cancer	0.000253	0.00461	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PLCB2—prostate cancer	0.00025	0.00457	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PRKCQ—prostate cancer	0.000246	0.00448	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HSD17B1—prostate cancer	0.000244	0.00445	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CTBP2—prostate cancer	0.000244	0.00445	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PLAUR—prostate cancer	0.000243	0.00443	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PDE4D—prostate cancer	0.000239	0.00436	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—GNRH1—prostate cancer	0.000237	0.00433	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—VIP—prostate cancer	0.000237	0.00433	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PLXNB1—prostate cancer	0.000234	0.00427	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—GRP—prostate cancer	0.00023	0.00419	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—LPAR1—prostate cancer	0.00023	0.00419	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PLCB2—prostate cancer	0.000227	0.00415	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—GNG5—prostate cancer	0.000227	0.00415	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—VAV3—prostate cancer	0.000225	0.00411	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GRPR—prostate cancer	0.000225	0.00411	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CX3CL1—prostate cancer	0.000223	0.00407	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—ITPR1—prostate cancer	0.000219	0.00399	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IL17RD—prostate cancer	0.000217	0.00397	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PDE4D—prostate cancer	0.000217	0.00396	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—GNG5—prostate cancer	0.000206	0.00376	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PTHLH—prostate cancer	0.000198	0.00361	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—WNT4—prostate cancer	0.000194	0.00354	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—JUP—prostate cancer	0.000194	0.00354	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—ITGB3—prostate cancer	0.000194	0.00353	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—ANXA1—prostate cancer	0.000186	0.0034	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RALBP1—prostate cancer	0.000185	0.00337	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MC2R—prostate cancer	0.000185	0.00337	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PTHLH—prostate cancer	0.00018	0.00328	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PRKACB—prostate cancer	0.000176	0.00321	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CALCA—prostate cancer	0.000174	0.00318	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PPP3CA—prostate cancer	0.000172	0.00313	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PLAU—prostate cancer	0.00017	0.00311	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CXCL12—prostate cancer	0.00017	0.00311	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—ANXA1—prostate cancer	0.000169	0.00308	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—CAV1—prostate cancer	0.000166	0.00304	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PENK—prostate cancer	0.000165	0.00301	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CALCA—prostate cancer	0.000158	0.00289	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GHR—prostate cancer	0.000157	0.00287	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PRKCQ—prostate cancer	0.000155	0.00283	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CXCL12—prostate cancer	0.000155	0.00282	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CG—prostate cancer	0.000152	0.00276	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NRP1—prostate cancer	0.000151	0.00275	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—EGF—prostate cancer	0.00015	0.00273	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—ADRB2—prostate cancer	0.000146	0.00266	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—VAV3—prostate cancer	0.000142	0.0026	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PRKCQ—prostate cancer	0.000141	0.00257	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—CREBBP—prostate cancer	0.000141	0.00256	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GNRH1—prostate cancer	0.00014	0.00256	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—VIP—prostate cancer	0.00014	0.00256	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—IGF1—prostate cancer	0.000139	0.00253	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—ITPR1—prostate cancer	0.000138	0.00252	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—LPAR1—prostate cancer	0.000136	0.00248	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GRP—prostate cancer	0.000136	0.00248	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PLCB2—prostate cancer	0.000134	0.00245	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—LRP2—prostate cancer	0.000134	0.00245	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CD—prostate cancer	0.000133	0.00243	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—ADRB2—prostate cancer	0.000133	0.00242	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—SERPINE1—prostate cancer	0.000132	0.0024	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—P4HB—prostate cancer	0.000132	0.0024	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CX3CL1—prostate cancer	0.000132	0.0024	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—VAV3—prostate cancer	0.000129	0.00236	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HIST1H2BG—prostate cancer	0.000129	0.00236	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GRB7—prostate cancer	0.000128	0.00234	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PDE4D—prostate cancer	0.000128	0.00234	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—NOS3—prostate cancer	0.000126	0.0023	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—ITPR1—prostate cancer	0.000125	0.00229	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HIST1H4H—prostate cancer	0.000125	0.00228	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—JAK2—prostate cancer	0.000122	0.00223	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GNG5—prostate cancer	0.000122	0.00222	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CB—prostate cancer	0.000116	0.00212	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—IL2—prostate cancer	0.000107	0.00195	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PTHLH—prostate cancer	0.000106	0.00194	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TGFBR1—prostate cancer	0.000106	0.00194	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—AKR1C3—prostate cancer	0.000104	0.00191	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PRKACB—prostate cancer	0.000104	0.0019	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—THBS1—prostate cancer	0.000101	0.00185	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PPP3CA—prostate cancer	0.000101	0.00185	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ANXA1—prostate cancer	9.99e-05	0.00182	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PRKCZ—prostate cancer	9.8e-05	0.00179	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CG—prostate cancer	9.58e-05	0.00175	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—EP300—prostate cancer	9.57e-05	0.00175	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGFR4—prostate cancer	9.47e-05	0.00173	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PARP1—prostate cancer	9.47e-05	0.00173	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CALCA—prostate cancer	9.35e-05	0.00171	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—SRC—prostate cancer	9.31e-05	0.0017	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CXCL12—prostate cancer	9.13e-05	0.00167	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—VEGFA—prostate cancer	9.07e-05	0.00165	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CG—prostate cancer	8.7e-05	0.00159	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CASP9—prostate cancer	8.6e-05	0.00157	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CD—prostate cancer	8.42e-05	0.00154	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PRKCQ—prostate cancer	8.33e-05	0.00152	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NGFR—prostate cancer	8.33e-05	0.00152	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—TGFB1—prostate cancer	8.32e-05	0.00152	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MAP3K7—prostate cancer	8.24e-05	0.0015	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGF10—prostate cancer	7.92e-05	0.00144	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ADRB2—prostate cancer	7.84e-05	0.00143	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—JAK2—prostate cancer	7.73e-05	0.00141	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—KRAS—prostate cancer	7.71e-05	0.00141	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—MAP2K1—prostate cancer	7.7e-05	0.0014	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CD—prostate cancer	7.65e-05	0.00139	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—VAV3—prostate cancer	7.64e-05	0.00139	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TGFBR2—prostate cancer	7.53e-05	0.00137	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ITPR1—prostate cancer	7.41e-05	0.00135	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CB—prostate cancer	7.34e-05	0.00134	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IGF1R—prostate cancer	7.09e-05	0.00129	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CA—prostate cancer	7.08e-05	0.00129	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CXCL8—prostate cancer	7.06e-05	0.00129	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—JAK2—prostate cancer	7.02e-05	0.00128	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—TP53—prostate cancer	6.85e-05	0.00125	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—LPL—prostate cancer	6.79e-05	0.00124	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—IL2—prostate cancer	6.74e-05	0.00123	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PDGFRB—prostate cancer	6.73e-05	0.00123	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CB—prostate cancer	6.67e-05	0.00122	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ITGB3—prostate cancer	6.56e-05	0.0012	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CXCL8—prostate cancer	6.41e-05	0.00117	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ERBB3—prostate cancer	6.36e-05	0.00116	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGFR2—prostate cancer	6.36e-05	0.00116	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—IL2—prostate cancer	6.12e-05	0.00112	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TERT—prostate cancer	6.1e-05	0.00111	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HIF1A—prostate cancer	5.83e-05	0.00106	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—AKT1—prostate cancer	5.79e-05	0.00106	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—LEP—prostate cancer	5.7e-05	0.00104	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CAV1—prostate cancer	5.64e-05	0.00103	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—KDR—prostate cancer	5.58e-05	0.00102	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ESR1—prostate cancer	5.44e-05	0.000992	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—BAD—prostate cancer	5.31e-05	0.000968	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—APC—prostate cancer	5.14e-05	0.000937	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CG—prostate cancer	5.14e-05	0.000937	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—EGF—prostate cancer	5.08e-05	0.000927	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IRS1—prostate cancer	5.08e-05	0.000927	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GSK3B—prostate cancer	4.93e-05	0.0009	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—INS—prostate cancer	4.87e-05	0.000887	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CREBBP—prostate cancer	4.77e-05	0.000869	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IGF1—prostate cancer	4.71e-05	0.000858	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—EGFR—prostate cancer	4.68e-05	0.000854	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MAP2K1—prostate cancer	4.55e-05	0.00083	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CD—prostate cancer	4.52e-05	0.000824	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CA—prostate cancer	4.48e-05	0.000816	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SERPINE1—prostate cancer	4.47e-05	0.000815	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—KRAS—prostate cancer	4.42e-05	0.000807	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGF2—prostate cancer	4.33e-05	0.000789	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NOS3—prostate cancer	4.27e-05	0.000778	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—JAK2—prostate cancer	4.15e-05	0.000756	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CA—prostate cancer	4.06e-05	0.000741	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MDM2—prostate cancer	4.05e-05	0.000738	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ERBB2—prostate cancer	3.99e-05	0.000728	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CB—prostate cancer	3.94e-05	0.000718	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CXCL8—prostate cancer	3.78e-05	0.00069	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CDKN1B—prostate cancer	3.7e-05	0.000674	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—AKT1—prostate cancer	3.66e-05	0.000667	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CASP3—prostate cancer	3.62e-05	0.000661	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IL2—prostate cancer	3.62e-05	0.00066	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—IL6—prostate cancer	3.6e-05	0.000656	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CCND1—prostate cancer	3.53e-05	0.000643	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CTNNB1—prostate cancer	3.49e-05	0.000637	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MMP9—prostate cancer	3.42e-05	0.000624	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CDKN1A—prostate cancer	3.41e-05	0.000622	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PTEN—prostate cancer	3.4e-05	0.000621	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—AKT1—prostate cancer	3.32e-05	0.000606	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—EP300—prostate cancer	3.25e-05	0.000592	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SRC—prostate cancer	3.16e-05	0.000576	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—VEGFA—prostate cancer	3.07e-05	0.000561	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—STAT3—prostate cancer	3.04e-05	0.000555	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MYC—prostate cancer	2.83e-05	0.000516	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TGFB1—prostate cancer	2.82e-05	0.000515	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—EGFR—prostate cancer	2.77e-05	0.000505	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—KRAS—prostate cancer	2.61e-05	0.000477	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CA—prostate cancer	2.4e-05	0.000438	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TP53—prostate cancer	2.32e-05	0.000424	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IL6—prostate cancer	2.13e-05	0.000388	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—AKT1—prostate cancer	1.96e-05	0.000358	CbGpPWpGaD
